Production (Stage)
Minerva Neurosciences, Inc.
NERV
$1.84
$0.052.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.29M | 21.36M | 26.53M | 30.88M | 34.82M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 534.80K | 806.90K | 1.31M | 428.00K | 702.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Current Assets | 17.92M | 22.27M | 27.94M | 31.41M | 35.62M |
|
|
|||||
| Total Current Assets | 17.92M | 22.27M | 27.94M | 31.41M | 35.62M |
| Net Property, Plant & Equipment | 4.10K | 5.40K | 6.80K | 8.20K | 9.50K |
| Long-term Investments | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M |
| Goodwill | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M |
| Total Other Intangibles | -- | -- | -- | 4.30K | 10.60K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 32.80M | 37.14M | 42.81M | 46.29M | 50.51M |
|
|
|||||
| Total Accounts Payable | 639.90K | 1.61M | 553.20K | 828.30K | 1.44M |
| Total Accrued Expenses | 1.31M | 1.23M | 3.93M | 3.38M | 1.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.95M | 2.84M | 4.48M | 4.20M | 2.83M |
|
|
|||||
| Total Current Liabilities | 1.95M | 2.84M | 4.48M | 4.20M | 2.83M |
| Long-Term Debt | 60.00M | 60.00M | 60.00M | 86.58M | 84.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.95M | 62.84M | 64.48M | 90.78M | 87.10M |
|
|
|||||
| Common Stock & APIC | 369.98M | 369.68M | 369.43M | 369.13M | 368.80M |
| Retained Earnings | -399.13M | -395.38M | -391.10M | -413.62M | -405.38M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -29.15M | -25.69M | -21.67M | -44.49M | -36.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.15M | -25.69M | -21.67M | -44.49M | -36.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.15M | -25.69M | -21.67M | -44.49M | -36.59M |
|
|
|||||